BamSEC and AlphaSense Join Forces
Learn More

Horizon Therapeutics Plc

Formerly NASDAQ: HZNP
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from 10-Q 3 pages Third Supplemental Indenture
12/34/56
EX-4.6
from 10-Q 3 pages Second Supplemental Indenture
12/34/56
EX-4.5
from 10-Q 3 pages First Supplemental Indenture
12/34/56
EX-4.6
from 10-K 13 pages Description of Share Capital
12/34/56
EX-4.1
from 8-K 139 pages Horizon Pharma USA, Inc. 5.500% Senior Notes Due 2027 Indenture Dated as of July 16, 2019 U.S. Bank National Association, as Trustee
12/34/56
EX-4.1
from 8-K 41 pages Horizon Pharma Public Limited Company Rights Agreement Dated as of February 28, 2019
12/34/56
EX-4.16
from 10-K 5 pages Seventh Supplemental Indenture
12/34/56
EX-4.16
from 10-K 5 pages Seventh Supplemental Indenture
12/34/56
EX-4.15
from 10-K 4 pages Third Supplemental Indenture
12/34/56
EX-4.15
from 10-K 4 pages Third Supplemental Indenture
12/34/56
EX-4.14
from 10-Q 5 pages Sixth Supplemental Indenture
12/34/56
EX-4.13
from 10-Q 4 pages Fifth Supplemental Indenture
12/34/56
EX-4.12
from 10-Q 4 pages Fourth Supplemental Indenture
12/34/56
EX-4.11
from 10-Q 4 pages Third Supplemental Indenture
12/34/56
EX-4.10
from 10-Q 4 pages Second Supplemental Indenture
12/34/56
EX-4.9
from 10-Q 4 pages Second Supplemental Indenture
12/34/56
EX-4.8
from 10-Q 4 pages First Supplemental Indenture
12/34/56
EX-4.1
from 8-K 141 pages Horizon Pharma, Inc. and Horizon Pharma USA, Inc. 8.750% Senior Notes Due 2024 Indenture Dated as of October 25, 2016 U.S. Bank National Association, as Trustee
12/34/56
EX-4.1
from 8-K 136 pages Horizon Pharma Financing Inc. 6.625% Senior Notes Due 2023 Indenture Dated as of April 29, 2015 U.S. Bank National Association, Trustee
12/34/56
EX-4.1
from 8-K 128 pages Horizon Pharma Investment Limited, as Issuer Horizon Pharma Public Limited Company, as Guarantor and U.S. Bank National Association, as Trustee Indenture Dated as of March 13, 2015 2.50% Exchangeable Senior Notes Due 2022
12/34/56